Ascendis Pharma A/S Current Liabilities
Ascendis Pharma A/S (ASND) had Current Liabilities of EUR 1.07 billion as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2026-02-11
- 2025-12-31: Current Liabilities 1.07B EUR.
- 2025-09-30: Current Liabilities 986.48M EUR.
- 2025-06-30: Current Liabilities 935.00M EUR.
- 2025-03-31: Current Liabilities 885.51M EUR.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 1.07B EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 986.48M EUR 6-K · filed 2025-11-12 | |
| 2025-06-30 | 935.00M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 885.51M EUR 6-K · filed 2025-05-01 | |
| 2024-12-31 | 907.86M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 838.46M EUR 6-K · filed 2024-11-14 | |
| 2024-06-30 | 847.74M EUR 6-K · filed 2024-09-03 | |
| 2024-03-31 | 798.97M EUR 6-K · filed 2024-05-02 | |
| 2023-12-31 | 736.51M EUR 20-F · filed 2025-02-12 | 197.34M EUR 20-F · filed 2024-02-07 |
| 2023-09-30 | 212.76M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 192.27M EUR 6-K · filed 2023-09-05 | |
| 2023-03-31 | 198.36M EUR 6-K · filed 2023-04-27 | |
| 2023-01-01 | 716.78M EUR 20-F · filed 2025-02-12 | |
| 2022-12-31 | 171.27M EUR 20-F · filed 2024-02-07 | |
| 2022-09-30 | 142.84M EUR 6-K · filed 2022-11-02 | |
| 2022-06-30 | 115.13M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 95.36M EUR 6-K · filed 2022-05-11 | |
| 2021-12-31 | 100.36M EUR 20-F · filed 2023-02-16 | |
| 2021-09-30 | 116.12M EUR 6-K · filed 2021-11-10 | |
| 2021-06-30 | 70.30M EUR 6-K · filed 2021-08-27 | |
| 2021-03-31 | 72.93M EUR 6-K · filed 2021-05-27 | |
| 2020-12-31 | 52.80M EUR 20-F · filed 2022-03-02 | |
| 2020-09-30 | 64.43M EUR 6-K · filed 2020-11-12 | |
| 2020-06-30 | 54.37M EUR 6-K · filed 2020-08-27 | |
| 2020-03-31 | 41.81M EUR 6-K · filed 2020-05-19 | |
| 2019-12-31 | 47.99M EUR 20-F · filed 2021-03-10 | |
| 2019-09-30 | 42.53M EUR 6-K · filed 2019-11-18 | |
| 2019-06-30 | 60.62M EUR 6-K · filed 2019-08-28 | |
| 2019-03-31 | 32.06M EUR 6-K · filed 2019-05-30 | |
| 2018-12-31 | 38.92M EUR 20-F · filed 2020-04-03 | |
| 2017-12-31 | 23.77M EUR 20-F · filed 2019-04-03 | |
| 2016-12-31 | 13.46M EUR 20-F · filed 2018-03-28 |